Kyto Biopharma, Inc. has accepted the resignation of Georges Benarroch as President and Chief Executive Officer and elected Mr. Benarroch as Chairman of the Board of Directors. He remains Corporate Secretary and Treasurer. Dr. Paul Russo has been appointed President and Chief Executive Officer and has been elected a Director of the
Corporation. Simon P. Westbrook has been appointed Chief Financial Officer of the Corporation. Peter Prendergast has resigned as Director of the Corporation.